about
Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cellsFarnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cellsAkt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cells.Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.Estrogen receptor (ER)alpha and ER beta are both expressed in human ejaculated spermatozoa: evidence of their direct interaction with phosphatidylinositol-3-OH kinase/Akt pathway.The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytesBergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination.Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter.Expression of nuclear insulin receptor substrate 1 in breast cancer.G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts.Crosstalk between IGF signaling and steroid hormone receptors in breast cancer.Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferationInteraction between estrogen receptor alpha and insulin/IGF signaling in breast cancer.The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness.Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines.Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters.Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development.Evidences that estrogen receptor α interferes with adiponectin effects on breast cancer cell growth.Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation.PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells.Evidence that bergapten, independently of its photoactivation, enhances p53 gene expression and induces apoptosis in human breast cancer cells.Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells.The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships.Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells.17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells.Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells.Human ejaculated spermatozoa contain active P450 aromatase.Towards a physiological role for cytochrome P450 aromatase in ejaculated human sperm.Progesterone through progesterone receptors affects survival and metabolism of pig sperm.Red wine consumption may affect sperm biology: the effects of different concentrations of the phytoestrogen myricetin on human male gamete function.Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.Controlled release of sunitinib in targeted cancer therapy: smart magnetically responsive hydrogels as restricted access materialsMagnetic molecularly imprinted polymers (MMIPs) for carbazole derivative release in targeted cancer therapySperm metabolism in pigs: a role for peroxisome proliferator-activated receptor gamma (PPAR )Adnexal Gland Secretion Markers in Unexplained AsthenozoospermiaDealing with Skin and Blood-Brain Barriers: The Unconventional Challenges of Mesoporous Silica NanoparticlesFollow-up study of thyroid function in polytransfused thalassemic patients
P50
Q28202098-890ED352-6C7C-49B6-BA96-425C8A1EF84AQ28571177-D255513D-93BA-4A01-89D9-5F785C8FAA71Q33614071-62F968D1-7199-41FC-B983-5AB4DB0BA47BQ34122589-3E87678E-2EDD-4067-9383-F31EE9741C6DQ34303291-2694A074-2E10-44A1-BB50-8A1D2DB9BBBDQ34314290-E2BDC121-E0FF-4059-B14E-CD3E4C62CBB3Q34696040-A9596197-7286-4642-8003-47EA7092C122Q35786199-2AE044A1-A9D7-4AE4-B1C0-FB1AFB38E012Q35794268-D48004EE-5FF4-46C9-A46A-E62FCBF1A043Q35954427-02E4044D-290B-4EA6-B3E4-9FFDDE7211F7Q36481702-DFAAC65E-C409-46E2-B0DA-6F168A1BFE00Q36754667-C1CA3506-B2C8-4391-BEFE-C16A4A7150DFQ36796668-B55D307B-3370-4DFC-A679-4F5405A8093AQ37062022-575F867E-E616-4BCF-BF9D-A49E945B4BA1Q37320077-F0DEEF96-B06D-46DD-992F-EDE777EC8096Q37492303-BDF1307C-8568-4406-B7D3-3746BF79AEF6Q37690691-83FADFE5-BDC5-4F31-B17B-CC5943691B17Q38337562-BD5E43BC-CF00-4193-B465-0DAB0A178966Q38918424-D7A98DAF-1465-4D90-B7F6-C26551D43411Q39043755-F6CFE2AA-1CCB-4B6D-ABB3-70B33E3BF6F9Q39321742-B18CA211-6169-4F0C-8225-3FC35843A286Q39513662-5315382C-9954-42EC-B200-40C1CD6CBDA8Q39801970-CDEB6135-D0FF-4FDF-AD1C-2D9B7082B325Q39839386-B0013234-37B3-4C4D-8FF0-C7960471DCC4Q39975924-32C4F3ED-6882-4D6C-8AC9-83789D6AE67FQ40076441-68D95B1D-4C82-4960-88F3-E5DAEA538F41Q40505823-7A3A9F19-6C0A-43D8-9DE3-1CAD39089A3CQ43201593-6EBFA6D5-3552-4B0A-BD5E-3421844BCA51Q43486137-AC707863-F0E2-4456-B858-90F94C2D8C89Q44055231-C4CFFE4C-8623-48B3-B187-8C9CC1A452B6Q44519325-CC524F4D-8E3A-45A6-95FA-BFBAA914D6C8Q48638380-5CA8A5D0-2827-4B37-9578-005AB4C3A217Q50497693-B1C73D44-705B-4EFF-8F33-7287A4E61E76Q54473491-8048624B-21A4-454C-BCEB-30F72BBA74E1Q57366482-CE913204-FB17-4988-A05D-DD3475A2886DQ59342620-A846A7A2-E472-48B2-93F3-F58D1FFE36C0Q60287189-EB43FDDB-61F1-4E19-AC79-25E0D4B47C26Q60287220-C4427A7F-AD9B-4C61-9AE5-6BB61629167DQ60923150-8665EE4F-02AA-406D-952D-754EED7EBA11Q60989496-D93460EF-17C0-4760-9E39-E5D25DA9A880
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Diego Sisci
@ast
Diego Sisci
@en
Diego Sisci
@es
Diego Sisci
@nl
Diego Sisci
@sl
type
label
Diego Sisci
@ast
Diego Sisci
@en
Diego Sisci
@es
Diego Sisci
@nl
Diego Sisci
@sl
prefLabel
Diego Sisci
@ast
Diego Sisci
@en
Diego Sisci
@es
Diego Sisci
@nl
Diego Sisci
@sl
P106
P1153
6701828472
P21
P31
P496
0000-0001-6577-1541